Key result
Bone marrow-derived mesenchymal stem cells provided greater improvement in cardiac muscle structure and more extensively reduced collagen fibers compared to curcumin in cyclophosphamide-treated rats.
Why the study?
Cyclophosphamide causes multiple organ toxicity including prominent cardiotoxicity, prompting evaluation of the potential therapeutic role of bone marrow-derived mesenchymal stem cells compared with curcumin.
Do bone marrow-derived mesenchymal stem cells or curcumin improve cyclophosphamide-induced cardiotoxicity in a rat model?
Do bone marrow-derived mesenchymal stem cells or curcumin improve cyclophosphamide-induced cardiotoxicity in a rat model?
Bone marrow-derived mesenchymal stem cells provide superior protection against cyclophosphamide-induced cardiotoxicity compared to curcumin in a rat model.
Hypothesis-generating for stem cell therapy in cyclophosphamide cardiotoxicity; clinical translation requires prospective human trials.
Introduction: Cyclophosphamide (CP) is used as a chemotherapeutic and an immunosuppressive agent. CP is known to cause multiple organ toxicity; the most obvious is cardiotoxicity. Aim: Possibile therapeutic effect on bone marrow -derived mesenchymal stem cells (BM-MSCs) in ameliorating CP- induced cardiotoxicity compared with Curcumin in albino rats. Methods: Fifty male albino rats were divided into five groups: group I received intraperitoneal injection of sterile water; group II received oral curcumin (200 mg/kg); group III received only one intraperitoneal injection of CP (200 mg/kg) and were sacrificed on day 40; group IV received the same treatment as group III followed by oral administration of curcumin from day 10 and were sacrificed on day 40; group V received the same treatment as group III followed by a single BM- MSCs injection intraperitoneally at a dose of 1×106 cells/ rat on day 10 and were sacrificed on day 40. Results: Histological structure of the cardiac muscle by light and electron microscopic examination revealed marked structural changes in rats treated with CP alone. Improvement in BM-MSCs group more than curcumin treated group was observed. Immunohistochemical staining of the cardiac muscle showed strong positive immunoreactivity for caspase-3 in group III compared to the control and other groups. Also, BM-MSCs extensively reduced the amount of collagen fibers compared with other groups. Conclusion: The use of curcumin has a limited beneficial effect on the protection of cardiac muscle against CP toxicity compared with stem cells.
No takes yet. Share an insight, caveat, or question.
Helal et al. (2020) studied Cyclophosphamide-induced cardiotoxicity (n=50). Bone marrow-derived mesenchymal stem cells (BM-MSCs) and Curcumin vs. Cyclophosphamide alone and sterile water was evaluated on Histological structure, caspase-3 immunoreactivity, and collagen fibers. Bone marrow-derived mesenchymal stem cells provided greater improvement in cardiac muscle structure and more extensively reduced collagen fibers compared to curcumin in cyclophosphamide-treated rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: